As of the latest SEC filings, AbCellera Biologics Inc. (ABCL) is held by 21 institutional funds. The largest fund shareholder is SMALLCAP World Fund Inc (SMCWX), holding an estimated $46,630,225.04 in market value, representing 0.06% of its portfolio.
Funds holding AbCellera Biologics Inc. (ABCL)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ABCL
- CIK:
- 0001703057
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
SMCWX
SMALLCAP World Fund Inc
|
MF | Independent / Boutique | 0.06% | $46,630,225.04 | 13,361,096 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.07% | $6,044,756.78 | 1,732,022 | Mar 31, 2026 | May 28, 2026 |
|
SPDW
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF
|
ETF | State Street (SPDR) | 0.01% | $1,971,459.12 | 564,888 | Mar 31, 2026 | May 28, 2026 |
|
IDNA
iShares Genomics Immunology and Healthcare ETF
|
ETF | BlackRock / iShares | 1.06% | $1,706,849.35 | 411,289 | Apr 30, 2026 | Jun 25, 2026 |
|
BDSKX
BlackRock Advantage Small Cap Core Fund
|
MF | BlackRock / iShares | 0.03% | $1,229,288.03 | 340,523 | Feb 27, 2026 | Apr 24, 2026 |
|
DMCRX
Driehaus Micro Cap Growth Fund
|
MF | Independent / Boutique | 0.19% | $869,847.60 | 249,240 | Mar 31, 2026 | May 27, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $638,829.21 | 176,961 | Feb 28, 2026 | Apr 24, 2026 |
|
GWX
State Street(R) SPDR(R) S&P(R) International Small Cap ETF
|
ETF | State Street (SPDR) | 0.07% | $573,494.25 | 164,325 | Mar 31, 2026 | May 28, 2026 |
|
ONEQ
Fidelity Nasdaq Composite Index ETF
|
ETF | Fidelity | 0.01% | $487,707.39 | 135,099 | Feb 28, 2026 | Apr 24, 2026 |
|
-
Adara Smaller Companies Fund
|
ETF | Independent / Boutique | 0.06% | $433,784.82 | 120,162 | Feb 28, 2026 | Apr 28, 2026 |
|
NOSGX
Small Cap Value Fund
|
MF | Independent / Boutique | 0.07% | $431,754.88 | 123,712 | Mar 31, 2026 | May 28, 2026 |
|
BBC
Virtus Biotech Clinical Trials Etf
|
ETF | Independent / Boutique | 0.85% | $316,416.75 | 76,245 | Apr 30, 2026 | Jun 22, 2026 |
|
AVUS
Avantis U.S. Equity ETF
|
ETF | American Century | 0.00% | $233,967.71 | 64,811 | Feb 28, 2026 | Apr 29, 2026 |
|
BXMYX
Blackstone Alternative Multi-Strategy Fund
|
MF | Independent / Boutique | 0.01% | $232,434.00 | 66,600 | Mar 31, 2026 | May 27, 2026 |
|
PDN
Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF
|
ETF | Invesco | 0.05% | $183,766.15 | 44,281 | Apr 30, 2026 | Jun 29, 2026 |
|
DSMZX
Destinations Small-Mid Cap Equity Fund
|
MF | Independent / Boutique | 0.02% | $159,612.54 | 44,214 | Feb 28, 2026 | Apr 28, 2026 |
|
AVSC
Avantis U.S. Small Cap Equity ETF
|
ETF | American Century | 0.01% | $143,692.44 | 39,804 | Feb 28, 2026 | Apr 29, 2026 |
|
-
Diversified Equity Master Portfolio
|
ETF | Independent / Boutique | 0.00% | $61,734.61 | 17,689 | Mar 31, 2026 | May 28, 2026 |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
ETF | Invesco | 0.08% | $60,373.64 | 16,724 | Feb 28, 2026 | Apr 28, 2026 |
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
ETF | ProShares | 0.05% | $49,897.42 | 13,822 | Feb 28, 2026 | Apr 24, 2026 |
|
AVUSX
Avantis U.S. Equity Fund
|
MF | American Century | 0.00% | $33,013.45 | 9,145 | Feb 28, 2026 | Apr 29, 2026 |
Advertisement (320x50)